1. Elevated Levels of the Polo Kinase Cdc5 Override the Mec1/ATR Checkpoint in Budding Yeast by Acting at Different Steps of the Signaling Pathway
- Author
-
Marco Muzi-Falconi, Achille Pellicioli, Federico Lazzaro, Paolo Plevani, Roberto A. Donnianni, Benjamin Tamilselvan Nachimuthu, Matteo Ferrari, Michela Clerici, Donnianni, R, Ferrari, M, Lazzaro, F, Clerici, M, Tamilselvan Nachimuthu, B, Plevani, P, Muzi Falconi, M, and Pellicioli, A
- Subjects
Cancer Research ,Cell cycle checkpoint ,Saccharomyces cerevisiae Proteins ,lcsh:QH426-470 ,DNA repair ,Molecular Sequence Data ,BIO/18 - GENETICA ,Cell Cycle Proteins ,Saccharomyces cerevisiae ,Biology ,Protein Serine-Threonine Kinases ,Cell Biology/Cell Signaling ,polo kinase, double strand breaks, S. cerevisiae ,Cyclin-dependent kinase ,Genetics ,DNA Breaks, Double-Stranded ,CHEK1 ,Amino Acid Sequence ,Molecular Biology ,Checkpoint Kinase 2 ,Genetics and Genomics/Cancer Genetics ,Genetics (clinical) ,Ecology, Evolution, Behavior and Systematics ,Molecular Biology/Recombination ,Biochemistry/Replication and Repair ,Molecular Biology/DNA Repair ,Polo kinase ,Intracellular Signaling Peptides and Proteins ,Molecular Biology/Chromosome Structure ,Cell cycle ,G2-M DNA damage checkpoint ,Cell biology ,lcsh:Genetics ,enzymes and coenzymes (carbohydrates) ,biology.protein ,biological phenomena, cell phenomena, and immunity ,Cell Nucleus Division ,Protein Kinases ,Research Article ,Signal Transduction - Abstract
Checkpoints are surveillance mechanisms that constitute a barrier to oncogenesis by preserving genome integrity. Loss of checkpoint function is an early event in tumorigenesis. Polo kinases (Plks) are fundamental regulators of cell cycle progression in all eukaryotes and are frequently overexpressed in tumors. Through their polo box domain, Plks target multiple substrates previously phosphorylated by CDKs and MAPKs. In response to DNA damage, Plks are temporally inhibited in order to maintain the checkpoint-dependent cell cycle block while their activity is required to silence the checkpoint response and resume cell cycle progression. Here, we report that, in budding yeast, overproduction of the Cdc5 polo kinase overrides the checkpoint signaling induced by double strand DNA breaks (DSBs), preventing the phosphorylation of several Mec1/ATR targets, including Ddc2/ATRIP, the checkpoint mediator Rad9, and the transducer kinase Rad53/CHK2. We also show that high levels of Cdc5 slow down DSB processing in a Rad9-dependent manner, but do not prevent the binding of checkpoint factors to a single DSB. Finally, we provide evidence that Sae2, the functional ortholog of human CtIP, which regulates DSB processing and inhibits checkpoint signaling, is regulated by Cdc5. We propose that Cdc5 interferes with the checkpoint response to DSBs acting at multiple levels in the signal transduction pathway and at an early step required to resect DSB ends., Author Summary Double strand DNA breaks (DSBs) are dangerous chromosomal lesions that can lead to genome rearrangements, genetic instability, and cancer if not accurately repaired. Eukaryotes activate a surveillance mechanism, called DNA damage checkpoint, to arrest cell cycle progression and facilitate DNA repair. Several factors are physically recruited to DSBs, and specific kinases phosphorylate multiple targets leading to checkpoint activation. Budding yeast is a good model system to study checkpoint, and most of the factors involved in the DSBs response were originally characterized in this organism. Using the yeast Saccharomyces cerevisiae, we explored the functional role of polo kinase Cdc5 in regulating the DSB–induced checkpoint. Polo kinases have been previously involved in checkpoint inactivation in all the eukaryotes, and they are frequently overexpressed in cancer cells. We found that elevated levels of Cdc5 affect the cellular response to a DSB at different steps, altering DNA processing and overriding the signal triggered by checkpoint kinases. Our findings suggest that Cdc5 likely regulates multiple factors in response to a DSB and provide a rationale for a proteome-wide screening to identify targets of polo kinases in yeast and human cells. Such information may have a practical application to design specific molecular tools for cancer therapy. Two related papers published in PLoS Biology—by Vidanes et al., doi:10.1371/journal.pbio.1000286, and van Vugt et al., doi:10.1371/journal.pbio.1000287—similarly investigate the phenomenon of checkpoint adaptation/overriding.
- Published
- 2010